Cutamesine
| Names | |
|---|---|
| Preferred IUPAC name 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine | |
| Identifiers | |
| 
 | |
| 3D model (JSmol) | 
 | 
| ChEMBL | 
 | 
| ChemSpider | |
| DrugBank | |
| PubChem CID | |
| UNII | 
 | 
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C23H32N2O2 | |
| Molar mass | 368.521 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Cutamesine (SA 4503) is a synthetic sigma receptor agonist which is selective for the σ1 receptor, a chaperone protein mainly found in the endoplasmic reticulum of cells in the central nervous system. These σ1 receptors play a key role in the modulation of Ca2+ release and apoptosis. Cutamesine's activation of the σ1 receptor is tied to a variety of physiological phenomena in the CNS, including activation of dopamine-releasing neurons and repression of the MAPK/ERK pathway.